Erenumab (Aimovig) was the first anti-CGRP agent approved by the FDA for migraine prophylaxis.
Ahmed Banawan, PharmD
Advertisement
Articles by Ahmed Banawan, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Experimental Multistage Malaria Vaccine Demonstrates Promising Protection in Early Trial
2
Reimagining Pharmacy: A Call to Action for Pharmacy Professionals
3
FDA Approves Milestone Oral Therapy for Adults With Thalassemia Anemia
4
A Healthy Gut Could Improve Mental Health
5